Current concepts on the use of glucocorticosteroids and beta-2-adrenoreceptor agonists to treat childhood asthma
about
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vilanterol, a Novel Inhaled Long-Acting β-Agonist, in Children Aged 5-11 Years with Persistent Asthma: A Randomized Trial.Scientific rationale for the use of alpha-adrenergic agonists and glucocorticoids in the therapy of pediatric stridor.
P2860
Current concepts on the use of glucocorticosteroids and beta-2-adrenoreceptor agonists to treat childhood asthma
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Current concepts on the use of ...... ists to treat childhood asthma
@en
Current concepts on the use of ...... sts to treat childhood asthma.
@nl
type
label
Current concepts on the use of ...... ists to treat childhood asthma
@en
Current concepts on the use of ...... sts to treat childhood asthma.
@nl
prefLabel
Current concepts on the use of ...... ists to treat childhood asthma
@en
Current concepts on the use of ...... sts to treat childhood asthma.
@nl
P2860
P1476
Current concepts on the use of ...... ists to treat childhood asthma
@en
P2093
Gustavo Nino
Michael M Grunstein
P2860
P304
P356
10.1097/MOP.0B013E328337CB0C
P577
2010-06-01T00:00:00Z